Related Experiment Videos

[A trial of using a dry bifidobacterin preparation with newborn risk groups to prevent acute intestinal infections]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|January 1, 1994
PubMed

Insights

Administering bifidumbacterin to newborns positively influenced intestinal microflora formation. This probiotic preparation reduced acute enteric infections by three times in infants during their first three months.

Area of Science:

  • Microbiology
  • Pediatrics
  • Gastroenterology

Background:

  • Infant gut microbiome development is crucial for health.
  • Early life infections pose significant risks to newborns.
  • Probiotics are explored for modulating infant gut microbiota.

Purpose of the Study:

  • To evaluate the effect of bifidumbacterin on infant intestinal microflora.
  • To assess the prophylactic efficacy of bifidumbacterin against infections in newborns.

Main Methods:

  • A randomized controlled trial involving newborn infants.
  • Administration of dried bifidumbacterin preparation to the test group.
  • Bacteriological analysis of intestinal microflora and infection surveillance.

Main Results:

  • Bifidumbacterin positively impacted the formation of intestinal microflora.
  • Infants receiving bifidumbacterin had 3x fewer acute enteric infections in the first 3 months.
  • A notable prophylactic effect was observed against skin and buccal mucosa infections.

Conclusions:

  • Bifidumbacterin is effective in promoting healthy infant gut microbiota.
  • This probiotic demonstrates significant protective effects against common infant infections.
  • Bifidumbacterin shows promise as a prophylactic agent for newborns.

Related Concept Videos